Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan

TY - JOUR

T1 - Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan

AU - Sciberras, Emma

AU - Streatfeild, Jared

AU - Ceccato, Tristan

AU - Pezzullo, Lynne

AU - Scott, James G.

AU - Middeldorp, Christel M.

AU - Hutchins, Paul

AU - Paterson, Roger

AU - Bellgrove, Mark A.

AU - Coghill, David

N1 - The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded through the Australian Government under the Department of Health Mental Health program awarded to the Australian ADHD Professionals Association. ES is funded by a National Health and Medical Research Council Career Development Fellowship (NHMRC) (1110688) and a veski Inspiring Women’s Fellowship. MAB is supported by a NHMRC Senior Research Fellowship (Level B) Funding sources did not have a role in analysis or interpretation of data.

PY - 2022/1

Y1 - 2022/1

N2 - Objective: To determine the financial and non-financial costs of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan.  Method: The population costs of ADHD in Australia were estimated for the financial year 2018 to 2019 using a prevalence approach to cost estimation across all ages. Financial (healthcare, productivity, education and justice systems, and deadweight losses) and non-financial costs were measured (Disability Adjusted Life Years (DALYs)).  Results: The total social and economic cost of ADHD in 2018 to 2019 were US$12.76 billion (range US$8.40 billion to US$17.44 billion, with per person costs of US$15,664 per year). Productivity costs made up 81% of the total financial costs, followed by deadweight losses (11%), and health system costs (4%). Loss in terms of wellbeing was significant (US$5.31 billion).  Conclusion: There is a need to raise public awareness of the considerable socioeconomic impact and burden of ADHD in order to drive investment and policy decisions that improve identification and treatment of ADHD.

AB - Objective: To determine the financial and non-financial costs of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan.  Method: The population costs of ADHD in Australia were estimated for the financial year 2018 to 2019 using a prevalence approach to cost estimation across all ages. Financial (healthcare, productivity, education and justice systems, and deadweight losses) and non-financial costs were measured (Disability Adjusted Life Years (DALYs)).  Results: The total social and economic cost of ADHD in 2018 to 2019 were US$12.76 billion (range US$8.40 billion to US$17.44 billion, with per person costs of US$15,664 per year). Productivity costs made up 81% of the total financial costs, followed by deadweight losses (11%), and health system costs (4%). Loss in terms of wellbeing was significant (US$5.31 billion).  Conclusion: There is a need to raise public awareness of the considerable socioeconomic impact and burden of ADHD in order to drive investment and policy decisions that improve identification and treatment of ADHD.

KW - ADHD

KW - economic

KW - costs

KW - health care

KW - education

KW - justice

KW - wellbeing

U2 - 10.1177/1087054720961828

DO - 10.1177/1087054720961828

M3 - Article

C2 - 33047627

SN - 1087-0547

VL - 26

SP - 72

EP - 87

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

IS - 1

ER -